Prodrug AST-003 Improves the Therapeutic Index of the Multi-Targeted Tyrosine Kinase Inhibitor Sunitinib. [electronic resource]
Producer: 20160621Description: e0141395 p. digitalISSN:- 1932-6203
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antineoplastic Agents -- administration & dosage
- Benzoates -- administration & dosage
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Drug Synergism
- Drug Tolerance
- Esterases -- metabolism
- Female
- Humans
- Hydrolysis
- Indoles -- administration & dosage
- Mice
- Neoplasms -- drug therapy
- Phosphorylation -- drug effects
- Prodrugs -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Proto-Oncogene Proteins c-akt -- metabolism
- Pyrroles -- administration & dosage
- STAT3 Transcription Factor -- metabolism
- Sunitinib
- Tissue Distribution
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.